VIENNA — Treatment with a novel lysophosphatidic acid receptor 1 (LPA1) antagonist was associated with significant changes in baseline biomarkers...
pulmonary
The present study found that the overall BMI z-score and WC/Ht among obese children and adolescents were significantly reduced at...
